FDA approves brentuximab vedotin for the treatment of adult patients with primary cutaneous anaplastic large cell lymphoma or CD30-expressing mycosis fungoides
European Society for Medical Oncology News | Nov 15, 2017
More women than men are diagnosed with bowel cancer as an emergency despite extra GP visits
Cancer Research UK News | Nov 14, 2017
Big data analysis predicts risk of radiotherapy side effects
Cancer Research UK News | Nov 14, 2017
Novel open source software for drug combination analysis reveals complex effects of combining clinically used drugs
Uppsala University News | Nov 14, 2017
For cancer patients with HIV, immunotherapy appears safe
Fred Hutchinson Cancer Research Center News | Nov 14, 2017
Researchers discover promising new anticancer strategy
Scripps Research Institute News | Nov 14, 2017
First systematic study of infections after CAR T-cell therapy
Fred Hutchinson Cancer Research Center News | Nov 14, 2017
Bolstering fat cells offers new hope for treating blood cancer
Ottawa Hospital Research Institute News | Nov 14, 2017
Breast cancer study suggests review of treatment length
University of Oxford News | Nov 13, 2017
IUDs may have a surprising benefit: Protection against cervical cancer
University of Southern California Health News | Nov 13, 2017